Kelly Rogal

Kelly Rogal is a seasoned finance professional with extensive experience in investment research and analysis. Currently serving as a Sr. Research Analyst at Sands Capital since November 2024, Kelly previously held the position of Director - Healthcare Research Analyst at Wafra from December 2022 to December 2024, where notable positive attribution was achieved against benchmarks in 2023 and 2024 year-to-date. Prior to that, Kelly worked at Franklin Templeton in various roles, including Research Analyst and Portfolio Manager, from July 2017 to December 2022. Earlier experience includes analyst positions at BNP Paribas CIB and Oak Hill Advisors, L.P., as well as a Long/Short Equity Research Associate role at Falcon Point Capital from June 2009 to December 2014. Kelly is an alumnus of the University of California, Berkeley.